Showing 1 of 1 PublicationsRAC1 and MelanomaHalaban R. RAC1 and Melanoma. Clinical Therapeutics 2014, 37: 682-685. PMID: 25465943, PMCID: PMC4415501, DOI: 10.1016/j.clinthera.2014.10.027.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsMeSH KeywordsHumansMelanomaMutationProtein Kinase InhibitorsRac1 GTP-Binding ProteinSkin NeoplasmsConceptsNormal melanocyte proliferationCommon recurrent mutationDrug resistanceMEK inhibitorsMelanoma cellsOncogenic mutationsMelanomaRecurrent mutationsMelanocyte proliferationFunctional roleGood targetEctopic expressionLimited informationMutationsPatientsRac1Latest dataTherapyDownload Full List
RAC1 and MelanomaHalaban R. RAC1 and Melanoma. Clinical Therapeutics 2014, 37: 682-685. PMID: 25465943, PMCID: PMC4415501, DOI: 10.1016/j.clinthera.2014.10.027.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsMeSH KeywordsHumansMelanomaMutationProtein Kinase InhibitorsRac1 GTP-Binding ProteinSkin NeoplasmsConceptsNormal melanocyte proliferationCommon recurrent mutationDrug resistanceMEK inhibitorsMelanoma cellsOncogenic mutationsMelanomaRecurrent mutationsMelanocyte proliferationFunctional roleGood targetEctopic expressionLimited informationMutationsPatientsRac1Latest dataTherapy